NAACCR Item #3921: Residual Tumor Volume Post Cytoreduction
| Item # | Length | Source of Standard | Section Name | Year Implemented | Version Implemented | XML NAACCR ID | Parent XML Element |
|---|---|---|---|---|---|---|---|
| 3921 | 2 | NAACCR | Stage/Prognostic Factors | 2018 | 18 | residualTumVolPostCytoreduction | Tumor |
Required Status:
NPCR Collect: No recommendation
CoC Collect: Required, site specific
SEER Collect: Required, site specific
CCCR Collect: No recommendation
Description
Gross residual tumor after primary cytoreductive surgery is a prognostic factor for ovarian cancer and residual tumor volume after cytoreductive surgery is a prognostic factor for late stage ovarian cancers.
Rationale
Residual Tumor Volume Post Cytoreduction is a Registry Data Collection Variable listed in AJCC. It was previously collected as Ovary, CS SSF # 3.
Allowable Values
00, 50, 60, 70, 80, 97-99
Codes
| Code | Description |
|---|---|
| 00 | No gross residual tumor nodules |
| 50 | Residual tumor nodule(s) 1 centimeter (cm) or less |
| 60 | Residual tumor nodule(s) greater than 1 cm |
| 70 | Macroscopic residual tumor nodule(s), size not stated |
| 80 | Procedure described as optimal debulking and size of residual tumor nodule(s) not given |
| 97 | No cytoreductive surgery performed |
| 98 | Not applicable: Information not collected for this case (If this item is required by your standard setter, use of code 98 will result in an edit error.) |
| 99 | Not documented in medical record Residual tumor status after cytoreductive surgery not assessed or unknown if assessed |
Code Notes
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.